Dr. Mark D. Erickstad, MD

Dr. Erickstad practices at Texas Oncology PA in Longview, Texas.

Dr. Erickstad's NPI, 1972570307, was assigned on March 3, 2006. Dr. Erickstad graduated from UT Southwestern Medical Center in 1986. Dr. Erickstad holds Texas license H2362.

Dr. Erickstad's primary practice is Texas Oncology PA, at 802 Medical Cir, Longview, TX 75605 in Gregg County. The practice phone is (972) 997-8000.

Dr. Erickstad's primary practice is Texas Oncology PA in Longview, Texas. Dr. Erickstad is also affiliated with Longview Regional Medical Center. The medical group on file is Texas Oncology. Dmand AI also links Dr. Erickstad to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Erickstad practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Erickstad's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Erickstad is board certified in urology by the American Board of Urology. Dr. Erickstad is licensed in Texas.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney disease, kidney removal surgery and kidney stone disease among the conditions Dr. Erickstad treats.

CMS data shows 4,634 Medicare services from Dr. Erickstad across 23 procedure codes in 2024, for 846 Medicare patients. Medicare paid $179,555 for them.

CMS counts 846 Medicare patients who saw Dr. Erickstad in 2024. The largest group is 65 to 74, with 381 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Erickstad's median patient age at 74, with 28% women.

In 2024, Dr. Erickstad wrote 3,725 Medicare Part D claims for 809 patients. 94% of them were for generic drugs. CMS names the drug for 3,562 of them, across 31 drugs with 11 or more claims each, at $159,064 in total drug cost. In 2023, CMS named 3,204 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Erickstad for performance year 2024, reported through an alternative payment model (APM). Dr. Erickstad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Erickstad. Dr. Erickstad's most frequent co-authors are Claus G. Roehrborn, MD and Arthur Isaac Sagalowsky, MD.

CMS Open Payments shows 119 general payments to Dr. Erickstad from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 57% of the total. Teleflex LLC paid the most, $2,042.

Dmand AI lists 1 award for Dr. Erickstad.

Dr. Erickstad graduated from UT Southwestern Medical Center in 1986.

Dr. Erickstad is in network with 22 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.